Skip to content
Recall Observatory FDA recall evidence

Drug product

Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur Dist - Dhar, Madhya Pradesh - 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-319-60.

D-0092-2024

October 23, 2023

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 93263
Status
Ongoing
Classification
Class II
Quantity
16,944 bottles
Official record key
drug-enforcement:D-0092-2024

Official wording

Reason: Failed Dissolution Specifications: Out of specification for dissolution.

Code information: Lot # 17230388, Exp. 01/31/2025

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification